FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
December 11, 2003
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing information
to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange
Act of 1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
Total Pages: 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: December 11, 2003 By: /s/ Paul Chambers
-------------------
Paul Chambers
Company Secretary
2
Smith & Nephew plc T44(0)207 401 7476 We are Smith & Nephew
15 Adam Street F44(0)207 960 2350
London WC2N 6LA www.smith-nephew.com
England
BSN ACQUISITION OF CASTING & SPLINTING
BUSINESS OF DEPUY INC
11 December 2003
Smith & Nephew plc notes that BSN Medical, its 50/50 joint venture with
Beiersdorf AG, has today announced its intention to acquire the casting and
splinting business of DePuy, Inc., a Johnson & Johnson company, which has
global sales of $42m.
This acquisition, which will be financed out of the existing non-recourse bank
facilities of BSN Medical, is a further step in establishing BSN as a major
independent medical devices company.
The transaction is subject to merger clearance in a number of national
authorities in Europe. BSN hopes to complete the transaction by the end of the
first quarter of 2004.
About us
Smith & Nephew (LSE:SN, NYSE:SNN) is one of the world's leading medical
devices companies, specialising in Orthopaedics, Endoscopy and Advanced Wound
Management. Smith & Nephew ranks as the global leader in arthroscopy and
advanced wound management and is the fastest growing full-line orthopaedics
company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself in the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
7,500 employees and operates in 32 countries around the world, generating
sales of (GBP)1.1 billion.
Enquiries:
Smith & Nephew
Peter Nind Tel: +44 (0)20 7401 7646
Corporate Affairs Manager
Financial Dynamics
David Yates Tel: +44 (0)20 7831 3113
News